Last updated: 2026-09-07 16:56:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
iRadimed Corporation (IRMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $83.43, with a market capitalisation of $1.07B and a P/E ratio of 46.28. Over the past 52 weeks, its price has ranged from $67.84 to $107.90. This page covers its latest market performance, valuation, price trends and company information.
$1.07B | |
$85.96 | |
$107.90 | |
$6.26 | |
$86.59 | |
165.03K | |
128.01K | |
46.28 | |
$107.90 | |
$67.84 | |
1.48% | |
-- |
iRadimed Corporation (IRMD) last closed at $86.59 as of 2026-09-04 23:41:00, unchanged from the previous close of $86.59.
During the latest regular trading session, IRMD traded between $6.26 and $107.90, with a volume of 165.03K shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, iRadimed Corporation (IRMD) moved from $87.00 to $83.43, representing a decline of 4.10% ($3.57).
The stock traded between $83.28 and $88.40 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 101.42 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 38.9%
IRMD is currently trading at $83.43, placing it 38.9% of the way from its 52-week low of $67.84 to its 52-week high of $107.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 166 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of iRadimed Corporation (IRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.